Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics

Phase 3 Unknown 100 enrolled Gustave Roussy, Cancer Campus, Grand Paris

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics. It is an efficacy study in adults and children and a randomized prospective study.

Timeline

Start: 2005-05
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	—	—

Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics

Summary

Timeline

Drugs

Indications